Published in Arterioscler Thromb Vasc Biol on June 26, 2003
Low-dose aspirin and medical record-confirmed age-related macular degeneration in a randomized trial of women. Ophthalmology (2009) 1.62
A randomized trial of aspirin at clinically relevant doses and nitric oxide formation in humans. J Cardiovasc Pharmacol Ther (2010) 0.98
Implications of altered glutathione metabolism in aspirin-induced oxidative stress and mitochondrial dysfunction in HepG2 cells. PLoS One (2012) 0.94
Consistent aspirin use associated with improved arteriovenous fistula survival among incident hemodialysis patients in the dialysis outcomes and practice patterns study. Clin J Am Soc Nephrol (2008) 0.88
Cardiovascular involvement in autoimmune diseases. Biomed Res Int (2014) 0.82
Indomethacin potentiates acetylcholine-induced vasodilation by increasing free radical production. Br J Pharmacol (2004) 0.79
Aspirin increases nitric oxide formation in chronic stable coronary disease. J Cardiovasc Pharmacol Ther (2013) 0.79
Effectiveness of aspirin on double lumen permanent catheter efficacy in ESRD. Nephrourol Mon (2013) 0.77
Antioxidative effect of aspirin on vascular function of aged ovariectomized rats. Age (Dordr) (2013) 0.76
Cilostazol, Not Aspirin, Prevents Stenosis of Bioresorbable Vascular Grafts in a Venous Model. Arterioscler Thromb Vasc Biol (2015) 0.76
Impacts of metformin and aspirin on life history features and longevity of crickets: trade-offs versus cost-free life extension? Age (Dordr) (2015) 0.76
Protective effects of ginseng extracts and common anti-aggregant drugs on ischaemia-reperfusion injury. Cardiovasc J Afr (2015) 0.76
Effect of Aspirin on Spinal Cord Injury: An Experimental Study. Iran J Med Sci (2016) 0.75
Does the use of acetylsalicylic acid have an influence on our vision? Clin Interv Aging (2016) 0.75
Aspirin induces Nrf2-mediated transcriptional activation of haem oxygenase-1 in protection of human melanocytes from H2 O2 -induced oxidative stress. J Cell Mol Med (2016) 0.75
Positive influence of aspirin on coronary endothelial function: Importance of the dose. World J Cardiol (2013) 0.75
NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle. Br J Pharmacol (2002) 1.90
Identification of residues crucially involved in the binding of the heme moiety of soluble guanylate cyclase. J Biol Chem (2003) 1.61
The antioxidant defense protein heme oxygenase 1 is a novel target for statins in endothelial cells. Free Radic Biol Med (2004) 1.30
Heme oxygenase-1 induction may explain the antioxidant profile of aspirin. Biochem Biophys Res Commun (2003) 1.18
The possible roles of food-derived bioactive peptides in reducing the risk of cardiovascular disease. J Nutr Biochem (2008) 1.16
Residues stabilizing the heme moiety of the nitric oxide sensor soluble guanylate cyclase. Eur J Pharmacol (2005) 1.11
Beyond gastric acid reduction: proton pump inhibitors induce heme oxygenase-1 in gastric and endothelial cells. Biochem Biophys Res Commun (2006) 1.10
Aspirin reduces endothelial cell senescence. Biochem Biophys Res Commun (2005) 1.04
Dimerization region of soluble guanylate cyclase characterized by bimolecular fluorescence complementation in vivo. Mol Pharmacol (2007) 1.04
Tissue-specific effects of statins on the expression of heme oxygenase-1 in vivo. Biochem Biophys Res Commun (2006) 1.01
Identification of residues crucially involved in soluble guanylate cyclase activation. FEBS Lett (2006) 1.00
Mechanisms of nitric oxide independent activation of soluble guanylyl cyclase. Eur J Pharmacol (2003) 0.99
A randomized trial of aspirin at clinically relevant doses and nitric oxide formation in humans. J Cardiovasc Pharmacol Ther (2010) 0.98
Pharmacological profile of a novel H(2)S-releasing aspirin. Free Radic Biol Med (2008) 0.94
Antioxidant action of L-alanine: heme oxygenase-1 and ferritin as possible mediators. Biochem Biophys Res Commun (2004) 0.92
Gastroprotection by vitamin C--a heme oxygenase-1-dependent mechanism? Biochem Biophys Res Commun (2003) 0.92
Simvastatin-dependent up-regulation of heme oxygenase-1 via mRNA stabilization in human endothelial cells. Eur J Pharm Sci (2010) 0.89
Statin treatment increases formation of carbon monoxide and bilirubin in mice: a novel mechanism of in vivo antioxidant protection. Can J Physiol Pharmacol (2007) 0.89
The ACE inhibitory dipeptide Met-Tyr diminishes free radical formation in human endothelial cells via induction of heme oxygenase-1 and ferritin. J Nutr (2006) 0.88
Receptor binding assay for nitric oxide- and heme-independent activators of soluble guanylate cyclase. Anal Biochem (2003) 0.87
Endothelial protection by pentaerithrityl trinitrate: bilirubin and carbon monoxide as possible mediators. Exp Biol Med (Maywood) (2003) 0.85
Calcium pantothenate modulates gene expression in proliferating human dermal fibroblasts. Exp Dermatol (2009) 0.84
Preparation of heme-free soluble guanylate cyclase. Protein Expr Purif (2003) 0.84
Atrial natriuretic peptide reduces cyclosporin toxicity in renal cells: role of cGMP and heme oxygenase-1. Free Radic Biol Med (2002) 0.83
Heme oxygenase-1 induction may explain the antioxidant profile of pentaerythrityl trinitrate. Biochem Biophys Res Commun (2002) 0.83
Molecular mechanism and functional consequences of lansoprazole-mediated heme oxygenase-1 induction. World J Gastroenterol (2009) 0.82
A common pathway of nitric oxide release from AZD3582 and glyceryl trinitrate. Eur J Pharm Sci (2004) 0.81
Enhanced detection of hydrogen sulfide generated in cell culture using an agar trap method. Anal Biochem (2012) 0.81
Aspirin increases nitric oxide formation in chronic stable coronary disease. J Cardiovasc Pharmacol Ther (2013) 0.79
Heme oxygenase-1 is a novel target and antioxidant mediator of S-adenosylmethionine. Biochem Biophys Res Commun (2008) 0.78
New signaling routes for an old drug: lipoxin A4 might mediate heme oxygenase-1 induction by aspirin. Focus on "Novel lipid mediator aspirin-triggered lipoxin A4 induces heme oxygenase-1 in endothelial cells". Am J Physiol Cell Physiol (2005) 0.77
[Therapy with NO donors-antiatherogenic and antioxidant actions]. Herz (2004) 0.77
AZD3582 increases heme oxygenase-1 expression and antioxidant activity in vascular endothelial and gastric mucosal cells. Eur J Pharm Sci (2005) 0.76
Display glass for low-loss and high-density optical interconnects in electro-optical circuit boards with eight optical layers. Opt Express (2015) 0.75
[Colleges, pharmacy schools and graduate programs]. Med Monatsschr Pharm (2008) 0.75